Differential sensitivity of RIP3-proficient and deficient murine fibroblasts to camptothecin anticancer drugs

Acta Pharmacologica Sinica

Volumn 33, Issue 3, 2012, Pages 426-428

  He, Jin Xue ^a   Wang, Ying Qing ^a   Feng, Jian Ming ^a   Li, Jia Xin ^a   Xu, Lei ^a   Li, Xiao Hua ^a   Wang, Wei ^a   Huan, Xia Juan ^a   Jiang, Yi ^a   Yu, Bing ^a   Chen, Guang ^a   Miao, Ze Hong ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; CHIMMITECAN; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; FIBROBLAST; LETTER; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMPTOTHECIN; FIBROBLASTS; MICE; NECROSIS; NIH 3T3 CELLS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 84863267148     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.1     Document Type: Letter

References (11)

1. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11: 700-14.
2. Zhang DW, Zheng M, Zhao J, Li YY, Huang Z, Li Z, et al. Multiple death pathways in TNF-treated fibroblasts: RIP3-and RIP1-dependent and independent routes. Cell Res 2011; 21: 368-71.
3. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011; 471: 363-7.
4. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011; 471: 368-72.
5. Lu JV, Weist BM, van Raam BJ, Marro BS, Nguyen LV, Srinivas P, et al. Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A 2011; 108: 15312-17.
6. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325: 332-6.
7. He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNFalpha. Cell 2009; 137: 1100-11.
8. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009; 137: 1112-23.
9. Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006; 25: 4798-811. (Pubitemid 44187627)
10. Huang M, Miao ZH, Zhu H, Cai YJ, Lu W, Ding J. Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins. Mol Cancer Ther 2008; 7: 1440-49.
11. Rasheed ZA, Rubin EH. Mechanisms of resistance to topoisomerase I-targeting drugs. Oncogene 2003; 22: 7296-304. (Pubitemid 37487161)